BriaCell Therapeutics Corp. (BCTX)
3.575
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
3.54
-0.04
(-0.98%)
Pre-Market: 20:00
BriaCell Therapeutics Total Liabilities (Quarterly) : 3.662M for April 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 3.662M |
| January 31, 2026 | 3.381M |
| October 31, 2025 | 3.725M |
| July 31, 2025 | 4.316M |
| April 30, 2025 | 5.061M |
| January 31, 2025 | 6.137M |
| October 31, 2024 | 6.701M |
| July 31, 2024 | 8.557M |
| April 30, 2024 | 12.44M |
| January 31, 2024 | 20.55M |
| October 31, 2023 | 16.10M |
| July 31, 2023 | 30.94M |
| April 30, 2023 | 35.61M |
| January 31, 2023 | 35.44M |
| October 31, 2022 | 28.12M |
| July 31, 2022 | |
| April 30, 2022 | 0.6447M |
| January 31, 2022 | 0.8536M |
| October 31, 2021 | 0.7646M |
| July 31, 2021 | |
| April 30, 2021 | 7.215M |
| January 31, 2021 | 4.000M |
| October 31, 2020 | 3.675M |
| July 31, 2020 | 3.636M |
| April 30, 2020 | 3.193M |
| Date | Value |
|---|---|
| January 31, 2020 | 2.738M |
| October 31, 2019 | 1.295M |
| July 31, 2019 | 1.060M |
| April 30, 2019 | 0.5556M |
| January 31, 2019 | 1.544M |
| October 31, 2018 | 1.044M |
| July 31, 2018 | 1.341M |
| April 30, 2018 | 1.363M |
| January 31, 2018 | 0.329M |
| October 31, 2017 | 0.3277M |
| July 31, 2017 | 0.8829M |
| April 30, 2017 | 0.0138M |
| January 31, 2017 | 0.0076M |
| October 31, 2016 | 0.0329M |
| July 31, 2016 | 0.0487M |
| April 30, 2016 | 0.0775M |
| January 31, 2016 | 0.0802M |
| October 31, 2015 | 0.1051M |
| July 31, 2015 | 0.1172M |
| April 30, 2015 | 0.1207M |
| January 31, 2015 | 0.1189M |
| October 31, 2014 | 2.071M |
| July 31, 2014 | 1.841M |
| April 30, 2014 | 0.0793M |
| January 31, 2014 | 0.0792M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Edesa Biotech, Inc. | 3.91M |
| ProMIS Neurosciences, Inc. | 7.295M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.07M |
| Shareholders Equity (Quarterly) | 24.06M |
| Current Ratio | 7.072 |